MLM
69
2
LNC
68
3
ILMN
38
-4
HBI
56
6
CHK
69
4
YUM
56
2
RF
63
2
EIX
89
15
CAG
64
2
OXY
68
-3
MRO
67
-3
AIZ
57
3
NOV
40
-5
IRM
73
-3
WBA
67
4
CMI
67
2
APD
60
-2
NFLX
62
-4
KR
71
6
AFL
60
-2
MLM
69
2
LNC
68
3
ILMN
38
-4
HBI
56
6
CHK
69
4
YUM
56
2
RF
63
2
EIX
89
15
CAG
64
2
OXY
68
-3
MRO
67
-3
AIZ
57
3
NOV
40
-5
IRM
73
-3
WBA
67
4
CMI
67
2
APD
60
-2
NFLX
62
-4
KR
71
6
AFL
60
-2
Financhill
Back

US Physical Therapy 10K Form

Buy
58

USPH
US Physical Therapy

Last Price:
84.30
Seasonality Move:
1.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive USPH News And Ratings

See the #1 stock for the next 7 days that we like better than USPH

USPH Financial Statistics

Sales & Book Value

Annual Sales: $495.02M
Cash Flow: $13.82M
Price / Cash Flow: 19.22
Annual Sales: $23.62
Price / Book: 3.7

Profitability

EPS (TTM): 2.93000
Net Income (TTM): $37.08M
Gross Margin: $117.18M
Return on Equity: 12.55%
Return on Assets: 5.2%

US Physical Therapy Earnings Forecast

Key US Physical Therapy Financial Ratios

  • The Gross Profit Margin over the past 31 years for USPH is 23.67%.
  • The Selling, General & Administrative Expenses for USPH have been equal to 9.40% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 3.38% of Operating Income.
  • The Net Earning history of USPH is 5.62% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 17 years.

US Physical Therapy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Medical Care Facilities
Sector: Healthcare
Current Symbol: USPH
CUSIP: 90337L
Website: usph.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 1.43
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 36.31
Forward P/E Ratio: 29

USPH Technical Analysis vs Fundamental Analysis

Buy
58
US Physical Therapy (USPH) is a Buy

Is US Physical Therapy a Buy or a Sell?